Evolent Health Files 8-K

Ticker: EVH · Form: 8-K · Filed: Jan 13, 2025 · CIK: 1628908

Sentiment: neutral

Topics: 8-K, SEC-filing, reporting

Related Tickers: EVH

TL;DR

EVH filed an 8-K, standard reporting. Check exhibits for details.

AI Summary

Evolent Health, Inc. filed an 8-K on January 13, 2025, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial details or material events beyond the standard reporting requirements.

Why It Matters

This filing indicates Evolent Health is meeting its SEC reporting obligations. Investors should review the exhibits for any specific disclosures.

Risk Assessment

Risk Level: low — The filing is a routine 8-K for reporting purposes and does not appear to contain any new material information or risks.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to file Financial Statements and Exhibits.

What is the filing date of this 8-K?

The filing date of this 8-K is January 13, 2025.

What is the company's principal executive office address?

The company's principal executive office is located at 1812 N. Moore Street, Suite 1705, Arlington, Virginia, 22209.

What is Evolent Health, Inc.'s telephone number?

Evolent Health, Inc.'s telephone number is (571) 389-6000.

What is the Commission File Number for Evolent Health, Inc.?

The Commission File Number for Evolent Health, Inc. is 001-37415.

Filing Stats: 566 words · 2 min read · ~2 pages · Grade level 9.4 · Accepted 2025-01-13 16:57:29

Key Financial Figures

Filing Documents

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure As previously announced, Evolent Health, Inc. (the "Company") will present at the 43 rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, at 4:30 p.m. PT. A live webcast of the presentation will be accessible through the investor relations section of the Company's website. A copy of the Company's presentation is furnished as Exhibit 99.1 and is incorporated herein by reference. The Company may use this presentation in meetings with investors from time to time as well. The information furnished under 7.01 of this Report, including Exhibit 99.1 hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing made by the Company under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. Exhibit No. Description 99.1 Investor Presentation 104 The cover page from this Current Report on Form 8-K, formatted as Inline XBRL

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. EVOLENT HEALTH, INC. By: /s/ Jonathan D. Weinberg Name: Jonathan D. Weinberg Title: General Counsel and Secretary Date: January 13, 2025

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing